C. Redeuilh

发表

Acetonic Extract of Buxus sempervirens Induces Cell Cycle Arrest, Apoptosis and Autophagy in Breast Cancer Cells

L. Fritsch, Ouardia Ait-Mohamed, Valentine Battisti, 2011, PloS one.

Structure-activity relationships in platelet-activating factor (PAF). 11-From PAF-antagonism to phospholipase A(2) inhibition: syntheses and structure-activity relationships in 1-arylsulfamido-2-alkylpiperazines.

C. Mounier, C. Dong, C. Redeuilh, 2001, European journal of medicinal chemistry.

Design and modeling of new platelet-activating factor antagonists. 3. Relative importance of hydrophobicity and electronic distribution in piperazinic series.

G. Dive, C. Redeuilh, A. Lamouri, 1997, Journal of lipid mediators and cell signalling.

Platelet activating factor (PAF‐acether): total synthesis of 1‐O‐octadecyl 2‐O‐acetyl sn‐glycero‐3‐phosphoryl choline

C. Redeuilh, F. Heymans, J. Godfroid, 1980, FEBS letters.

Structure-activity relationships in platelet-activating factor (PAF). 7. Tetrahydrofuran derivatives as dual PAF antagonists and acetylcholinesterase inhibitors. Synthesis and PAF-antagonistic activity.

N. Blavet, G. Dive, C. Redeuilh, 1996, Journal of lipid mediators and cell signalling.

PAF receptor and “cache-oreilles” effect. Simple PAF antagonists

D. Hosford, P. Braquet, G. Dive, 1991, Lipids.

Inhibition of secretory phospholipase A2. 2-Synthesis and structure-activity relationship studies of 4,5-dihydro-3-(4-tetradecyloxybenzyl)-1,2,4-4H-oxadiazol-5-one (PMS1062) derivatives specific for group II enzyme.

C. Dong, C. Redeuilh, J. Huet, 2005, Bioorganic & medicinal chemistry.

Design of new potent and selective secretory phospholipase A(2) inhibitors. 6-Synthesis, structure-activity relationships and molecular modelling of 1-substituted-4-[4,5-dihydro-1,2,4-(4H)-oxadiazol-5-one-3-yl(methyl)]-functionalized aryl piperazin/one/dione derivatives.

G. Dive, C. Redeuilh, A. Lamouri, 2010, Bioorganic & medicinal chemistry.

Structure—Activity Relationships in Platelet‐Activating Factor (PAF). 11‐From PAF‐Antagonism to Phospholipase A2 Inhibition: Syntheses and Structure—Activity Relationships in 1‐Arylsulfamido‐2‐alkylpiperazines.

C. Mounier, C. Dong, C. Redeuilh, 2002 .

Diazonium salt-derived 4-(dimethylamino)phenyl groups as hydrogen donors in surface-confined radical photopolymerization for bioactive poly(2-hydroxyethyl methacrylate) grafts.

Y. Yagcı, C. Redeuilh, A. Lamouri, 2012, Langmuir : the ACS journal of surfaces and colloids.

Magnetic nanocrystals coated by molecularly imprinted polymers for the recognition of bisphenol A

C. Redeuilh, A. Lamouri, N. Griffete, 2012 .

Structure-activity relationship in PAF-acether. 3. Hydrophobic contribution to agonistic activity.

C. Redeuilh, C. Broquet, F. Heymans, 1987, Journal of medicinal chemistry.

Structure-activity relationships in platelet-activating factor. Part 13: synthesis and biological evaluation of piperazine derivatives with dual anti-PAF and anti-HIV-1 or pure antiretroviral activity.

G. Dive, C. Redeuilh, A. Lamouri, 2006, Bioorganic & medicinal chemistry.

Structure-activity relationships in platelet-activating factor (PAF). 10. From PAF antagonism to inhibition of HIV-1 replication.

D. Dormont, C. Dong, C. Redeuilh, 2000, Journal of medicinal chemistry.

Inhibition of secreted phospholipase A2. 4-glycerol derivatives of 4,5-dihydro-3-(4-tetradecyloxybenzyl)-1,2,4-4H-oxadiazol-5-one with broad activities.

G. Lambeau, C. Dong, C. Redeuilh, 2007, Journal of medicinal chemistry.